Analisis karakteristik molekuler resistensi HIV terhadap dolutegravir (DTG): A systematic review
Journal of Pharmacy and Tropical Issues · 18.10.2026 · 6 (6) · 466-474
DOI: 10.56922/pti.v6i6.23 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Pharmacy and Tropical Issues, online erschienen am 18.10.2026. Verfasst von Gavin Argatha Fullah und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Dolutegravir (DTG) is a second-generation integrase strand transfer inhibitor (INSTI) recommended by the World Health Organization (WHO) as a first-line antiretroviral therapy (ART) due to its high antiviral potency and high genetic barrier to resistance. However, Indonesia’s national transition toward DTG-based regimens has not been accompanied by a comprehensive synthesis of data regarding the molecular characteristics of HIV resistance to DTG. Consequently, the patterns of integrase gene mutations and the distribution of HIV-1 subtypes associated with INSTI resistance in Indonesia remain only partially understood and scattered across various literature sources.
Purpose
To synthesize available evidence on the molecular characteristics of HIV resistance to Dolutegravir (DTG) in Indonesia.
Method
This study employed a systematic review design, searching the PubMed, Scopus, and Google Scholar databases based on predefined inclusion and exclusion criteria. Data meeting these criteria were extracted and synthesized using a narrative synthesis approach.
Results
The most dominant HIV-1 subtype in cases of DTG resistance in Indonesia is CRF01_AE, which is consistently found in Java, Sumatra, and parts of Papua—with the exception of West Papua, where Subtype B predominates. Only one study reported data on integrase gene mutations, identifying major mutations such as R263K (1.4%) and Y143H (1.4%), as well as the combination of R263K + D232N (2.8%). The total prevalence of major INSTI-associated drug resistance mutations (DRMs) in the ART-treated/INSTI-naïve population was 5.6%.
Conclusion
The molecular characteristics of HIV resistance to DTG in Indonesia remain only partially understood due to a limited number of studies specifically analyzing the integrase gene; thus, molecular surveillance of INSTI resistance in Indonesia is still in its early stages. Keywords: Dolutegravir (DTG); HIV Resistance; Integrase Mutations. Pendahuluan: Dolutegravir (DTG) merupakan golongan Integrase Strand Transfer Inhibitor (INSTI) generasi kedua yang direkomendasikan World Health Organization (WHO) sebagai lini pertama terapi antiretroviral (ART) karena potensi antivirus tinggi dan genetic barrier yang tinggi terhadap resistensi. Namun, transisi nasional Indonesia menuju regimen berbasis DTG belum diiringi sintesis data karakteristik molekuler resistensi HIV terhadap DTG secara komprehensif, sehingga pola mutasi gen integrase dan distribusi subtipe HIV-1 terkait resistensi INSTI di Indonesia masih tergambar secara parsial dan tersebar di berbagai literatur. Tujuan: Untuk mensintesis bukti yang tersedia mengenai karakteristik molekuler resistensi HIV terhadap Dolutegravir (DTG) di Indonesia. Metode: Penelitian ini menggunakan desain systematic review pada basis data PubMed, Scopus, dan Google Scholar dengan menerapkan kriteria inklusi dan eksklusi yang telah ditetapkan. Data yang memenuhi kriteria diekstraksi dan disintesis menggunakan pendekatan narrative synthesis. Hasil: Subtipe HIV-1 yang paling dominan pada kasus resistensi DTG di Indonesia adalah CRF01_AE, ditemukan konsisten di Jawa, Sumatera, dan sebagian Papua, dengan pengecualian di Papua Barat yang didominasi Subtipe B. Hanya satu studi yang melaporkan data mutasi gen integrase, dengan temuan mutasi major R263K (1.4%), Y143H (1.4%), dan kombinasi R263K + D232N (2.8%), serta total prevalensi major INSTI Drug Resistance Mutation (DRM) sebesar 5.6% pada populasi ART-treated/INSTI-naïve. Simpulan: Karakteristik molekuler resistensi HIV terhadap DTG di Indonesia masih tergambar secara parsial akibat terbatasnya studi yang menganalisis gen integrase secara khusus, sehingga surveilans molekuler resistensi INSTI di Indonesia masih berada pada tahap awal. Kata Kunci: Dolutegravir (DTG); Mutasi Integrase; Resistensi HIV.
Zitieren
APA
Fullah, G. A., Hidayat, H., Hasbie, N. F., & Kurniati, M. (2026). Analisis karakteristik molekuler resistensi HIV terhadap dolutegravir (DTG): A systematic review. Journal of Pharmacy and Tropical Issues, 6(6), 466-474. https://doi.org/10.56922/pti.v6i6.23
Vancouver
Fullah GA, Hidayat H, Hasbie NF, Kurniati M. Analisis karakteristik molekuler resistensi HIV terhadap dolutegravir (DTG): A systematic review. Journal of Pharmacy and Tropical Issues. 2026;6(6):466-474. doi:10.56922/pti.v6i6.23
BibTeX
@article{Fullah2026,
author = {Fullah, Gavin Argatha and Hidayat, Hidayat and Hasbie, Neno Fitriyani and Kurniati, Mala},
title = {Analisis karakteristik molekuler resistensi HIV terhadap dolutegravir (DTG): A systematic review},
journal = {Journal of Pharmacy and Tropical Issues},
year = {2026},
volume = {6},
number = {6},
pages = {466--474},
doi = {10.56922/pti.v6i6.23}
}
EUVIMED